.Nature Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin caused strengthened progression-free and general survival, causing FDA commendation as well as a brand-new treatment choice for people.